Jean-Pierre Bouiller
Lid van de Investeringscommissie bij Sofimac Régions SAS
Profiel
Mr. Jean-Pierre Bouiller has a degree from Ecole Supérieure de Commerce in Clermont-Ferrand (1987).
He subsequently worked in accounting at Fiduciaire de France (Fidex) before joining Sofimac in October 1989.
Initially responsible for a portfolio of diversified investments, he was later entrusted with the management of sector-specific funds before being appointed Portfolio Manager for Sofimac in 1999 and Sofimac Croissance in 2005.
Actieve functies van Jean-Pierre Bouiller
Bedrijven | Functie | Begin |
---|---|---|
Sofimac Régions SAS
Sofimac Régions SAS Investment ManagersFinance Sofimac Régions SAS is a Private Equity/Venture Capital firm, a subsidiary of Sofimac Investment Managers SAS founded in 1978. Sofimac Régions is headquartered in Clermont-Ferrand. | Lid van de Investeringscommissie | 22-06-2010 |
Eerdere bekende functies van Jean-Pierre Bouiller
Bedrijven | Functie | Einde |
---|---|---|
Imaxio SA
Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Sofimac Régions SAS
Sofimac Régions SAS Investment ManagersFinance Sofimac Régions SAS is a Private Equity/Venture Capital firm, a subsidiary of Sofimac Investment Managers SAS founded in 1978. Sofimac Régions is headquartered in Clermont-Ferrand. | Finance |
Imaxio SA
Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Health Technology |